Dr. Keith A. Landesman<\/a>, a beloved son, father, and husband lost his life to cancer. Each year his parents Jane and Dick, along with their family and friends, honor his life and legacy by raising funds to support Cancer Research Institute postdoctoral fellows whose groundbreaking research expands our knowledge of cancer and its relationship to the immune system. Since 2013, the Cancer Research Institute Landesman Fundraiser has raised more than $2.5 million. These funds have supported young scientists working to find immunotherapies for breast, colorectal, lung, and ovarian cancers, glioblastoma, leukemia, and lymphoma.<\/p>\n\n\n\nAs always, you can be a part of this special cause and make a difference in the lives of those affected by cancer by registering today or giving to the Landesman Fundraiser.<\/p>\n\n\n\n
If you wish to mail in a contribution, please make your donation payable to Cancer Research Institute and send to:<\/p>\n\n\n\n
Landesman Fundraiser
c\/o Cancer Research Institute
29 Broadway, Floor 4
New York, NY 10006-3111<\/p>\n\n\n\n
Current CRI-Dr. Keith Landesman Memorial Fellows<\/strong><\/p>\n\n\n\nYitong Ma, PhD, Stanford University, 2024-present<\/span>
Programmable delivery of therapeutic gene editing molecules by engineered immune cells<\/em> Dr. Yitong Ma is addressing a significant challenge in cancer treatment\u2014 delivery of gene-editing material to cancer or immune cells at the right time and in the correct context. Cancers result from the accumulation of gene mutations, and recent advances in CRISPR-based technologies offer potential solutions to rectify these mutations by providing a means to edits specific genes.<\/p>\n\n\n\nWhy CRI? Why Immunotherapy?<\/strong><\/p>\n\n\n\n